These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 732035)

  • 21. [Behavior of aldosterone and plasma renin activity after ACTH administration and insulin-induced hypoglycemia in patients with essential arterial hypertension].
    Tosti-Croce C; Graziosi S; Giaquinto G; Sparano F; Sciarra F
    Minerva Med; 1981 Mar; 72(9):575-80. PubMed ID: 6264356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Blood volume, plasma renin activity and plasma aldosterone concentration in patients with essential hypertension who were treated for more than ten years (author's transl)].
    Nakamura Y
    Nihon Naika Gakkai Zasshi; 1980 Jun; 69(6):714-22. PubMed ID: 6997417
    [No Abstract]   [Full Text] [Related]  

  • 23. [Catecholamines in the blood and the renin-angiotensin-aldosterone axis in essential hypertension].
    Cerasola GA; Morici ML; Andronico G; Picciotto G; Cottone S; Bucalo M
    Boll Soc Ital Cardiol; 1981; 26(12):2279-91. PubMed ID: 6764360
    [No Abstract]   [Full Text] [Related]  

  • 24. Response of blood pressure and the renin-angiotensin-aldosterone axis to hypotensive therapy: comparison of propranolol with spironolactone.
    Espiner EA; Mansfield H; Miles K
    N Z Med J; 1977 Sep; 86(595):216-9. PubMed ID: 343004
    [No Abstract]   [Full Text] [Related]  

  • 25. [A reduced aldosterone response to infused angiotensin II in low renin essential hypertension (author's transl)].
    Hidaka H
    Nihon Naika Gakkai Zasshi; 1975 Aug; 64(8):797-808. PubMed ID: 1239475
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experience with an oral angiotensin I-converting enzyme inhibitor in hypertensive patients: effects on blood pressure and the renin-aldosterone system by a single dose (author's transl)].
    Mizuno K; Shigetomi S; Haruyama K; Matsui J; Gotho M; Fukuchi S
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):1-11. PubMed ID: 6247526
    [No Abstract]   [Full Text] [Related]  

  • 27. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
    Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
    Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study on the relationship between renin-angiotensin-aldosterone system and essential hypertension].
    Zhao GS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1982 Jun; 10(2):113-6. PubMed ID: 6751748
    [No Abstract]   [Full Text] [Related]  

  • 29. [Captopril in the treatment of hypertension (author's transl)].
    Favre L
    Schweiz Rundsch Med Prax; 1981 Aug; 70(35):1487-90. PubMed ID: 7024978
    [No Abstract]   [Full Text] [Related]  

  • 30. [The renin-angiotension-aldosterone system and cortisol excretion before, during and after enflurane anaesthesia for orthopaedic surgery (author's transl)].
    Hack G; Pless V; Vetter H
    Anasth Intensivther Notfallmed; 1980 Dec; 15(6):453-9. PubMed ID: 7013558
    [No Abstract]   [Full Text] [Related]  

  • 31. [Renin, angiotensin and aldosterone in the diagnosis of hypertension].
    Pasternack A; Fyhrqvist F
    Duodecim; 1975; 91(7):461-73. PubMed ID: 1140119
    [No Abstract]   [Full Text] [Related]  

  • 32. Aldosterone and its stimuli in normal and hypertensive man: are essential hypertension and primary hyperaldosteronism without tumour the same condition?
    Davies DL; Beevers DG; Brown JJ; Cumming AM; Fraser R; Lever AF; Mason PA; Morton JJ; Robertson JI; Titterington M; Tree M
    J Endocrinol; 1979 May; 81(2):79P-91P. PubMed ID: 458346
    [No Abstract]   [Full Text] [Related]  

  • 33. [Total body potassium in low renin essential hypertension with reference to the renin-angiotensin-aldosterone system (author's transl)].
    Suzuki S; Doi Y; Tasaki S; Aoi W; Kuramochi M; Hashiba K; Norimura T; Okajima S
    Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1522-8. PubMed ID: 744895
    [No Abstract]   [Full Text] [Related]  

  • 34. [Temporal aspects of the function of the renin-angiotensin-aldosterone system. Contribution to the methodological standardization of explorative test (author's transl)].
    Cugini P; Mancini A; Meucci T; Manconi R; Scavo D
    Ann Ist Super Sanita; 1979; 15(2):179-96. PubMed ID: 400073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between renin-aldosterone system and efficacy of a beta-blocking agent in hypertensive patients].
    Armanini D; Guido R; Fallo F; Opocher G; Mantero F
    Clin Ter; 1976 Oct; 79(1):41-62. PubMed ID: 1017163
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of an angiotensin II analogue upon blood pressure, plasma renin concentration and plasma aldosterone in hypertensive patients.
    Vierhapper H; Waldhäusl W
    Arzneimittelforschung; 1979; 29(8):1175-7. PubMed ID: 583019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of beta blockade on the renin-angiotensin-aldosterone system [proceedings].
    Lijnen PJ; Amery AK; Fagard RH
    Arch Int Physiol Biochim; 1979 Feb; 87(1):191-3. PubMed ID: 92268
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies of plasma renin activity in patients with hypertension.
    Kokot F; Kuska J; Czekala Z; Kiecoń I
    Pol Med J; 1968; 7(6):1319-27. PubMed ID: 4305122
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of losartan on the renin-angiotensin-aldosterone axis in essential hypertension.
    Bauer IH; Reams GP; Wu Z; Lau-Sieckman A
    J Hum Hypertens; 1995 Apr; 9(4):237-43. PubMed ID: 7595905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased adrenal sensitivity to angiotensin II in low-renin essential hypertension.
    Wisgerhof M; Brown RD
    J Clin Invest; 1978 Jun; 61(6):1456-62. PubMed ID: 659608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.